

Indosol Drugs Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 7.50 Cr
- Company Age 36 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 18.96 Cr
- Revenue Growth -28.30%
- Profit Growth -11.66%
- Ebitda -7.34%
- Net Worth -2.11%
- Total Assets -22.60%
About Indosol Drugs
Indosol Drugs Limited (IDL) is a Public Limited Indian Non-Government Company incorporated in India on 07 July 1988 and has a history of 36 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.50 Cr.
The company has closed loans amounting to ₹18.96 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Niranjan Shah, Chirag Shah, and Virendra Shah serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH1988PLC047992
- Company No.
047992
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Jul 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Indosol Drugs?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Niranjan Shah ![]() | Director | 06-Sep-2004 | Current |
Chirag Shah ![]() | Director | 23-Feb-1994 | Current |
Virendra Shah ![]() | Director | 07-Jul-1988 | Current |
Financial Performance of Indosol Drugs.
Indosol Drugs Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 28.3% decrease. The company also saw a substantial fall in profitability, with a 11.66% decrease in profit. The company's net worth dipped by a decrease of 2.11%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Indosol Drugs?
In 2022, Indosol Drugs had a promoter holding of 45.33% and a public holding of 54.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Indosol Synthochem Private Limited
Niranjan Shah is a mutual person
- Indosol Organics Private Limited
Niranjan Shah is a mutual person
- Chirag Construction Co Pvt Ltd
Niranjan Shah and Chirag Shah are mutual person
- Triumph Builders Llp
Niranjan Shah and Chirag Shah are mutual person
- Amey Realty & Construction Llp
Niranjan Shah and Chirag Shah are mutual person
- Triumph Real Estate Consultants Llp
Niranjan Shah and Chirag Shah are mutual person
Charges (Loans)
₹0
₹18.96 Cr
Charges Breakdown by Lending Institutions
- Central Bank Of India : 18.96 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
30 Apr 2002 | Central Bank Of India | ₹18.96 Cr | Satisfied |
How Many Employees Work at Indosol Drugs?
Indosol Drugs has a workforce of 4 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Indosol Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indosol Drugs's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Indosol Drugs
Recent activity within the organization
- Annual General Meeting
Indosol Drugs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Indosol Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Charges
A charge registered on 30 Apr 2002 via Charge ID 90232806 with Central Bank Of India was fully satisfied on 27 Nov 2013.
- Director Appointment
Niranjan Popatlal Shah was appointed as a Director was appointed as a Director on 06 Sep 2004 & has been associated with this company since 20 years 5 months .
- Charges
A charge with Central Bank Of India amounted to Rs. 18.96 Cr with Charge ID 90232806 was registered on 30 Apr 2002.
- Director Appointment
Chirag Ashok Shah was appointed as a Director was appointed as a Director on 23 Feb 1994 & has been associated with this company since 31 years 10 days .
Frequently asked questions
What is the Incorporation or founding date of Indosol Drugs Limited?
Indosol Drugs Limited was incorporated on 07 Jul 1988.
What is authorized share capital and paid-up capital of Indosol Drugs Limited?
The authorized share capital of Indosol Drugs Limited is ₹ 10.00 Cr and paid-up capital is ₹ 7.50 Cr.
Who are the current board members & directors of Indosol Drugs Limited?
Currently 3 directors are associated with Indosol Drugs Limited.
- Niranjan Popatlal Shah
- Chirag Ashok Shah
- Virendra Popatlal Shah
What is the registered address of Indosol Drugs Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Indosol Drugs Limited is 84- Floor-8 Plot-195 Arcadia Building Vinayak Kumar Shah Marg N C P A Narima Point, India, Mumbai, Maharashtra, 400021.
What is the corporate identification number (CIN) and company number of Indosol Drugs Limited?
The corporate identification number (CIN) of Indosol Drugs Limited is U24230MH1988PLC047992 and the company number is 047992 as per Ministry of Corporate Affairs (MCA).
What is the official website of Indosol Drugs Limited?
The Official website of Indosol Drugs Limited is https://www.indosolexports.com
What has been the recent revenue trend for Indosol Drugs Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Indosol Drugs Limited has fallen by -28.30%.
How many employees does Indosol Drugs Limited currently have?
As Per 2022 financial reports, 4 employees are currently employed by Indosol Drugs Limited.
What change has been observed in the net worth of Indosol Drugs Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Indosol Drugs Limited has experienced an downturn of -2.11%.
When was the last Balance Sheet of Indosol Drugs Limited filed with the ROC?
The most recent Balance Sheet for Indosol Drugs Limited was filed with the ROC on 31 Mar 2024.